$207.98
▲ +$4.77
(+2.35%)
Vol 1.3M
7
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$31.7B
ROE
-25.1%
Margin
-14.6%
D/E
6.42
Beta
1.66
52W
$125–$247
Wall Street Consensus
28 analysts · Apr 202610
Strong Buy
15
Buy
3
Hold
0
Sell
0
Strong Sell
89.3%
Buy Rating
Price Chart
Similar Stocks
VRTX
Vertex Pharmaceuticals Inc
P/E 31.3
$115.0B
REGN
Regeneron Pharmaceuticals Inc
P/E 17.7
$81.1B
ALNY
Alnylam Pharmaceuticals Inc
P/E 1205.9
$52.5B
INSM
Insmed Inc
$37.1B
BIIB
Biogen Inc
P/E 16.0
$25.8B
UTHR
United Therapeutics Corp
P/E 16.5
$21.0B
RVMD
Revolution Medicines Inc
$15.4B
MRNA
Moderna Inc
$11.5B
INCY
Incyte Corp
P/E 16.3
$19.4B
Earnings
Beat rate: 50.0%
Next Report
May 06, 2026
EPS Estimate: $-0.56
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $-0.56 | — | — |
| Dec 2025 | $-0.52 | $0.36 | +$0.88 |
| Sep 2025 | $-0.38 | $-0.64 | $-0.26 |
| Jun 2025 | $-0.63 | $-0.74 | $-0.11 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -22.2% | -22.2% | -22.2% | -22.2% | -25.1% | -25.1% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -18.5% | -12.9% | -12.9% | -12.9% | -14.6% | -14.6% |
| Gross Margin | 63.4% | 62.9% | 62.9% | 62.9% | 63.7% | 63.7% |
| D/E Ratio | 6.45 | 6.45 | 6.45 | 6.45 | 6.42 | 6.42 |
| Current Ratio | 3.72 | 3.72 | 3.72 | 3.72 | 3.27 | 3.27 |
Key Ratios
ROA (TTM)
-17.7%
P/S (TTM)
14.97
P/B
17.5
EPS (TTM)
$-2.28
CF/Share
$-4.30
Rev Growth 3Y
+39.5%
52W High
$246.90
52W Low
$125.38
$125.38
52-Week Range
$246.90
How does NTRA compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
NTRA valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
15.0
▲
17%
above
peers
(12.9)
vs Peers
vs Industry
Pricier
P/B ratio
17.5
▲
611%
above
peers
(2.5)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
NTRA profitability vs Biotechnology peers
ROE
-25.1%
▲
63%
above
peers
(-67.3%)
vs Peers
vs Industry
Top tier
Net margin
-14.6%
▲
95%
above
peers
(-286.8%)
vs Peers
vs Industry
Below avg
Gross margin
63.7%
▼
19%
below
peers
(78.6%)
vs Peers
vs Industry
Weak
ROA
-17.7%
▲
62%
above
peers
(-46.7%)
vs Peers
vs Industry
Top tier
NTRA financial health vs Biotechnology peers
D/E ratio
6.4
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
High debt
Current ratio
3.3
▼
26%
below
peers
(4.4)
vs Peers
vs Industry
Low liquidity
Beta
1.7
▲
71%
above
peers
(1.0)
vs Peers
vs Industry
More volatile
NTRA fundamentals radar
NTRA
Peer median
Industry
NTRA profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
NTRA vs peers: key metrics
Latest News
DHS Rescinds Policy Requiring Secretary Review Of Contracts Above $100,000
ZeroHedge · Apr 05
Contractor that cut back 500-year-old oak in London park identified
The Guardian · Apr 03
Services Sector Contraction In March Screams Q1 Stagflation
ZeroHedge · Apr 03
Plug Power Stock Rises 6% After Securing Front-End Engineering Design Contract
Nasdaq · Apr 02
Pratt & Whitney Granted $6.6 Bln F135 Engine Production Contract For F-35 …
Nasdaq · Mar 31